Loading
institutionsInstitution
European Society for Radiotherapy and Oncology
Europe's radiation oncology society, running the ESTRO congress, a school that trains much of the world's radiotherapy workforce, and the standards behind brachytherapy and adaptive radiotherapy.
Also called: ESTRO
Overview
Founded in 1980, ESTRO represents radiation oncologists, physicists, radiobiologists and radiation therapists across Europe and beyond. Its annual congress is the main European venue for radiotherapy trials, its ESTRO School has taught courses for decades across the world, and it publishes Radiotherapy & Oncology (the Green Journal), Clinical and Translational Radiation Oncology and physics and technical journals. ESTRO consensus guidelines on target volume delineation, GEC-ESTRO brachytherapy recommendations and its ACROP practice guidelines are used globally, and its HERO project quantifies the gap between radiotherapy need and capacity in Europe. ESTRO Vision 2030 argues for radiotherapy for every patient who needs it.
Location
Brussels, BE
Type
consortium
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#331 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking
- ESTRO annual congress
- ESTRO School
- GEC-ESTRO brachytherapy and ACROP guidelines
- HERO health economics project
Barbara Jereczek-Fossa
President
Radiation oncologyProstate cancer radiotherapyStereotactic radiotherapy
Milan radiation oncologist leading ESTRO, Europe's radiotherapy and oncology society.
Charlotte E. Coles
Professor of Breast Cancer Clinical Oncology, University of Cambridge; Consultant, Addenbrooke's Hospital
Breast radiotherapyPartial breast irradiationHypofractionation
Led IMPORT LOW, which showed partial-breast radiotherapy is as effective as whole-breast treatment with fewer side effects.
Matthias Guckenberger
Past-President
Stereotactic body radiotherapyOligometastatic diseaseLung cancer radiotherapy
Zurich radiation oncologist and ESTRO Past-President, a leading voice on stereotactic radiotherapy for oligometastases.
Vincenzo Valentini
Professor of Radiation Oncology, Università Cattolica; Gemelli
Radiation oncologyRectal cancerPredictive modelling
Vincenzo Valentini is a radiation oncologist known for rectal cancer chemoradiation and outcome modelling.
Uwe Oelfke
Head of Joint Department of Physics, ICR and Royal Marsden
Radiotherapy physicsMR-guided radiotherapyAdaptive radiotherapy
Uwe Oelfke is the radiotherapy physicist behind the Marsden's pioneering MR-linac programme.
Jürgen Debus
Head of Radiation Oncology, Heidelberg University Hospital; Director, HIT Heidelberg Ion-Beam Therapy Center
Particle therapyCarbon-ion radiotherapyRadiation oncology
Jürgen Debus leads Europe's pioneering heavy-ion therapy centre.
Similar pages
- IdeaA regulatory pathway for new radiotherapy techniques modelled on drug development
Shares Jürgen Debus, Carbon-ion therapy, MR-guided adaptive radiotherapy, Surgery and radiotherapy cure most, get least.
- IdeaRadiotherapy for everyone who needs it by 2040
Shares Brachytherapy, Surgery and radiotherapy cure most, get least, SBRT / SABR (stereotactic radiotherapy), Most of the world has almost no cancer care.
- JournalClinical oncology
Shares Uwe Oelfke, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam).
- IdeaCore-funded radiotherapy trials infrastructure with central quality assurance
Shares Uwe Oelfke, MR-guided adaptive radiotherapy, Surgery and radiotherapy cure most, get least, SBRT / SABR (stereotactic radiotherapy).
- IdeaPay for a course of radiotherapy, not for each fraction
Shares American Society for Radiation Oncology, Surgery and radiotherapy cure most, get least, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam).
- IdeaPooled coverage-with-evidence for proton therapy across all centres
Shares Jürgen Debus, Carbon-ion therapy, Surgery and radiotherapy cure most, get least, Proton therapy.
- IdeaMake one-week radiotherapy the default in overloaded systems
Shares Surgery and radiotherapy cure most, get least, SBRT / SABR (stereotactic radiotherapy), Most of the world has almost no cancer care, IMRT / IGRT (modern external beam).
- JournalRadiation oncology
Shares Vincenzo Valentini, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam).